Client Overview
A growing pharmaceutical company developing breakthrough therapies needed to transform its accounting for IPO readiness.
The Challenge
Key obstacles included limited internal resources, complex regulations, tight timeline, SOX compliance needs, and knowledge gaps.
GRP’s Approach
- Technical expertise in controls and SEC reporting
- Hands-on support during IPO preparation
- Training for internal staff
Results
The company achieved:
- Successful IPO completion
- Clean audit opinion
- Empowered internal team
- Scalable infrastructure